Pbbm - Open Access .click

Results 51 to 60 of about 455 (133)

Accelerating Subcutaneous Drug Development: A Mechanistic Absorption Model for the Open Systems Pharmacology Framework. [PDF]

CPT Pharmacometrics Syst Pharmacol
ABSTRACT This study describes the implementation of a mechanistic subcutaneous (SC) injection model for the Open Systems Pharmacology platform. As the SC route of administration is gaining increased popularity, there is a growing need for tools to predict, analyze, and understand the SC absorption process and the mechanisms involved.
Pellowe M, Dubbelboer I, Sjögren E.
europepmc +2 more sources

CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative

Clinical Genetics, Volume 101, Issue 5-6, Page 481-493, May-June 2022., 2022
Abstract CIBER (Center for Biomedical Network Research; Centro de Investigación Biomédica En Red) is a public national consortium created in 2006 under the umbrella of the Spanish National Institute of Health Carlos III (ISCIII). This innovative research structure comprises 11 different specific areas dedicated to the main public health priorities in ...
Juan Luque +371 more
wiley +1 more source

Developing Clinically Relevant Dissolution Specifications for Oral Drug Products—Industrial and Regulatory Perspectives

Pharmaceutics, 2019
A meeting that was organized by the Academy of Pharmaceutical Sciences Biopharmaceutics and Regulatory Sciences focus groups focused on the challenges of Developing Clinically Relevant Dissolution Specifications (CRDS) for Oral Drug Products.
Mark McAllister +8 more
doaj +1 more source

Prediction of fasted and fed bioequivalence for immediate release drug products using physiologically based biopharmaceutics modeling (PBBM)

European Journal of Pharmaceutical Sciences, 2020
Bioequivalence studies are an integral part of clinical pharmacology strategy for drug development. Physiologically based biopharmaceutics modeling (PBBM) can be a helpful tool to assess potential bioequivalence risks and predict the outcome of bioequivalence studies.
Rebeka Jereb, Albin Kristl, Amitava Mitra +2 more
openaire +2 more sources

Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective

, 2023
CPT: Pharmacometrics &Systems Pharmacology, Volume 12, Issue 5, Page 556-559, May 2023.
Efthymios Manolis +10 more
wiley +1 more source

PBBM Global terima RM200j dari SMEsuccess [PDF]

, 2012
KUALA LUMPUR 15 Mei - SME Factors hari ini memeterai perjanjian dengan PBBM Global Corp.
Utusan, Malaysia
core +1 more source

Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series

Pharmaceutics, 2022
A webinar series that was organised by the Academy of Pharmaceutical Sciences Biopharmaceutics focus group in 2021 focused on the challenges of developing clinically relevant dissolution specifications (CRDSs) for oral drug products.
Mark McAllister +20 more
doaj +1 more source

Dr Mohd Shukor Mahfar kekal YDP PBBM [PDF]

, 2014
KOTA KINABALU: Yang Dipertua Persatuan Badan Berkanun Malaysia (PBBM) Tan Sri Dr Mohd Shukor Mahfar dan Naib Yang Dipertua Prof Datuk Dr Abdullah Mohamad Said daripada Universiti Teknologi Mara (UiTM) mengekalkan jawatan masing-masing bagi sesi 2014 ...
Harian Ekspress, (KK)
core +1 more source

Mohd Shukor retains PBBM Chief post [PDF]

, 2014
KOTA KINABALU: The Malaysian Statutory Bodies Association (PBBM) President, Tan Sri Dr Mohd Shukor Mahfar, and VicePresident, Prof Datuk Dr Abdullah Mohamed Said, from University Teknologi Mara (UiTM) will retain their positions for the 2014-2016 ...
Daily Express, (KK)
core +1 more source

ShangQingLiu/PBBM-robot-librarian: First release for IAS'18

, 2023
No description ...
ShangQingLiu
core +1 more source

pbpk
physiologically based biopharmaceutics modeling
bioequivalence

pharmacology
biorelevant dissolution
food effect

ibuprofen
clinically relevant dissolution specifications
therapeutics